Retro Biosciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Retro Biosciences, Inc. - overview
Established
2021
Location
Redwood City, CA-California, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2021, Retro Biosciences, Inc. , d. b. a.
Retro develops therapies primarily for diseases related to aging and adds more years to the human lifespan. The company was co-founded by Joe Betts-LaCroix (CEO), Matt Buckley, and Sheng Ding, and in May 2026, it raised an undisclosed amount of venture funding. The financing values Retro Biosciences, Inc. at USD 1.
8 billion post-money. Retro Biosciences provides cellular reprogramming, autophagy, and plasma-inspired therapeutics to increase a healthy human lifespan. The company will use the May 2026 funding to support its clinical trial in Alzheimer's disease and advance multiple technology platforms including gene therapies and cell replacement therapies.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.retro.bio/
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.